Wed, September 29, 2021
Tue, September 28, 2021
Mon, September 27, 2021
Sun, September 26, 2021
Fri, September 24, 2021
Thu, September 23, 2021
Wed, September 22, 2021
Tue, September 21, 2021
Mon, September 20, 2021
Fri, September 17, 2021
Thu, September 16, 2021
Wed, September 15, 2021
Tue, September 14, 2021

Jim Birchenough Maintained (ADAP) at Hold with Increased Target to $7 on, Sep 22nd, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-7-on-sep-22nd-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Jim Birchenough of Wells Fargo, Maintained "Adaptimmune Therapeutics plc" (ADAP) at Hold with Increased Target from $6 to $7 on, Sep 22nd, 2021.

Jim has made no other calls on ADAP in the last 4 months.



There are 2 other peers that have a rating on ADAP. Out of the 2 peers that are also analyzing ADAP, 1 agrees with Jim's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jonathan Chang of "SVB Leerink" Maintained at Hold with Increased Target to $7 on, Monday, September 13th, 2021


This is the rating of the analyst that currently disagrees with Jim


  • Peter Lawson of "Barclays" Initiated at Sell and Held Target at $4 on, Friday, May 28th, 2021

Publication Contributing Sources